CVS monthly performance report
Monthly CVS research: returns, drawdown, relative strength, seasonality, and key stats.
CVS monthly report
—
Key takeaways
- CVS Health (CVS) closed August 2026 at $99.12, down 5.08% for the month and +56.29% over the trailing 12 months.
- Year-to-date, CVS is +24.90%, outperforming the S&P 500 which has returned +12.89% YTD.
- The stock is trading +17.14% versus its 200-day moving average ($84.61), a bullish technical signal.
- Over the past three years, CVS has underperformed the S&P 500 by −36.30%, with a relative strength index reading of 78.5.
- Win rate over the trailing 39 months stands at 59% — 23 positive months versus 16 negative months.
CVS Health ended August 2026 at $99.12, posting a monthly return of −5.08%. The S&P 500 returned +3.05% over the same window, leaving relative performance at −8.13%.
The current quarter stands at −4.67% (Q3 2026 (QTD)), while medium-term trend remains constructive: price is +17.14% versus the 200-day moving average ($84.61).
Year-to-date, CVS is +24.90% against SPY +12.89%, a gap of +12.01%. The stock is currently −10.44% below its 52-week high, with maximum 3-year drawdown at −46.23%.
| Period | CVS | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | −5.08% | −0.20% | −4.88% |
| 1 Week | −9.35% | +3.90% | −13.25% |
| 1 Month | −5.08% | +3.05% | −8.13% |
| 3 Months | +19.01% | +7.11% | +11.89% |
| 6 Months |